The Scientist - Home

After a handful of cases in Ireland, clinicians there are warning that the virus might infect the placenta in very rare instances and cause fetal distress, but a rise in stillbirths has not been seen in epidemiological studies.

Scientists at the US CDC report no red flags in a preliminary analysis of the safety of Pfizer/BioNTech’s and Moderna’s mRNA-based immunizations among expectant mothers.

The genomes of the children of people exposed to fallout from the Chernobyl nuclear accident appear to carry no trace of the incident.

Men given high doses of two antihistamine drugs did not experience the same benefits of high intensity interval training that men on a placebo enjoyed, revealing some of the molecular underpinnings of exercise’s effect.

The pandemic continues to make it difficult for researchers to get reagents and other materials in high demand for COVID-19 research and testing, threatening experiments’ progress and scientists’ careers.

Cultivating stenophylla, untapped by the coffee industry for the last century, could help farmers cope with the effects of climate change, researchers suggest.

A founder of the field of synthetic biology is selling data from his own DNA as a nonfungible token, or NFT, through Nebula Genomics, a personal genome company he cofounded.

When conservationists relocate species, they don’t always account for the pathogens hitching a ride, and the consequences of introducing them to a new environment.

Priceless collections of books, manuscripts, and personal papers have been lost.

The continuous network of fluid-filled compartments crosses organ barriers and might serve as a conduit for tumor cells to spread.

A new ruling removes the requirement that grants and proposals using the material receive approval from an ethical review board, reverting to the process in place before 2019.

It’s unclear how long protections against infection will last from the initial vaccinations, and health authorities say additional jabs will likely be necessary.